ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 162 filers reported holding ACHILLION PHARMACEUTICALS IN in Q3 2014. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $413,000 | +74.3% | 98,195 | +71.0% | 0.01% | +83.3% |
Q4 2016 | $237,000 | +99.2% | 57,429 | +289.6% | 0.01% | +100.0% |
Q3 2016 | $119,000 | -71.9% | 14,741 | -72.9% | 0.00% | -66.7% |
Q2 2016 | $424,000 | +90.1% | 54,305 | +88.3% | 0.01% | +50.0% |
Q1 2016 | $223,000 | +7.7% | 28,843 | +50.5% | 0.01% | +50.0% |
Q4 2015 | $207,000 | +6.2% | 19,170 | -32.2% | 0.00% | +33.3% |
Q3 2015 | $195,000 | +75.7% | 28,272 | +125.1% | 0.00% | +50.0% |
Q2 2015 | $111,000 | -62.1% | 12,558 | -57.8% | 0.00% | -66.7% |
Q1 2015 | $293,000 | -55.6% | 29,752 | -55.0% | 0.01% | -53.8% |
Q3 2014 | $660,000 | +441.0% | 66,155 | +77.4% | 0.01% | +550.0% |
Q1 2014 | $122,000 | +159.6% | 37,282 | +165.4% | 0.00% | +100.0% |
Q4 2013 | $47,000 | 0.0% | 14,050 | -10.3% | 0.00% | 0.0% |
Q3 2013 | $47,000 | – | 15,656 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 13,633,220 | $56,305,000 | 7.98% |
BVF INC/IL | 2,423,300 | $10,008,000 | 2.01% |
EMORY UNIVERSITY | 454,102 | $1,875,000 | 1.85% |
DAFNA Capital Management LLC | 196,500 | $812,000 | 0.71% |
Orbimed Advisors | 13,107,200 | $54,133,000 | 0.69% |
RTW INVESTMENTS, LP | 286,285 | $1,182,000 | 0.44% |
Marcus Capital, LLC | 100,000 | $413,000 | 0.44% |
Rock Springs Capital Management LP | 1,375,000 | $5,679,000 | 0.38% |
Spark Investment Management LLC | 978,600 | $4,041,000 | 0.33% |
Bellevue Group AG | 240,000 | $991,000 | 0.20% |